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Abstract
Background: Physical activity (PA) is associated with lower risk of stroke. We tested the hypothesis that lack of pre-
stroke PA is an independent predictor of poor outcome after first-ever ischemic stroke.
Methods: We assessed recent self-reported PA and other potential predictors for loss of functional independence -
modified Rankin Scale (mRS) > 2 - one year after first-ever ischemic stroke in 1370 patients registered between 2006
and 2010 in the Ludwigshafen Stroke Study, a population-based stroke registry.
Results: After 1 year, 717 (52.3%) of patients lost their independence including 251 patients (18.3%) who had died.
In multivariate logistic regression analysis lack of regular PA prior to stroke (Odds Ratio (OR) 1.7, Confidence Interval
(CI) 1.1–2.5), independently predicted poor outcome together with higher age (65–74: OR 1.7; CI 1.1–2.8, 75–
84 years: OR 3.3; CI 2.1–5.3; ≥85 years OR 14.5; CI 7.4–28.5), female sex (OR 1.5; CI 1.1–2.1), diabetes mellitus (OR 1.8;
CI 1.3–2.5), stroke severity (OR 1.2; CI 1.1–1.2), probable atherothrombotic stroke etiology (OR 1.8; CI 1.1–2.8) and
high leukocyte count (> 9.000/mm3; OR 1.4; CI 1.0–1.9) at admission. Subclassifying unknown stroke etiology,
embolic stroke of unknown source (ESUS; n = 40, OR 2.2; CI 0.9–5.5) tended to be associated with loss of
independence.
Conclusion: In addition to previously reported factors, lack of PA prior to stroke as potential indicator of worse
physical condition, high leukocyte count at admission as indicator of the inflammatory response and probable
atherothrombotic stroke etiology might be independent predictors for non-functional independence in first-ever
ischemic stroke.
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Background
A high proportion of stroke survivors worldwide require
assistance or are fully dependent on caregivers for activ-
ities of daily living after stroke [1]. Improved individual-
ized therapy in acute ischemic stroke care, preemptive
therapy of risk factors or changes in lifestyle prior to
stroke may modify ischemic stroke (IS) outcome. Predic-
tion of functional outcome in patients with IS can sup-
port clinicians to improve effective stroke care,
anticipate discharge planning and support patients and
family to develop realistic expectations for long-term
care provision.
Clinical rating or imaging - based scoring systems like
ASTRAL, DRAGON or SEDAN have been published to
predict loss of functional independence after IS [2–5].
Age, initial stroke severity, onset to admission time,
range of visual fields, level of consciousness, glucose and
concentrations of serum neutrophil markers were some
predictors for losing functional independence in these
studies [6–11]. However, prognostic models had only
minor impact on clinical practice. The majority of these
scores were based on retrospective analysis of cases from
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hospital-based data [3, 12–18]. Few studies have system-
atically evaluated multiple factors in prospective and un-
selected data series of consecutive ischemic stroke
patients [19–23].
Physical activity (PA) activity before stroke as mea-
sured by self-report adds to the risk of poor outcome.
Epidemiologic studies have consistently suggested an
association between PA and the risk of stroke [24–27].
PA is recommended to reduce the risk of first-ever and
possibly the risk of recurrent stroke [24, 28–30]. Low PA
may lower the individual capacity to cope with the meta-
bolic and other stressful sequelae after cerebral ischemia.
The aim of this study was to identify predictors of
one-year-functional outcome in patients with first-ever
ischemic stroke, using five-year case series data from a
prospective, population-based stroke registry. In particu-
lar, we tested the hypothesis that lack of self-reported re-
cent PA increases risk of poor functional outcome after
IS. Besides the well-established risk-factors, inflamma-
tory parameters such as leukocyte count and fibrino-
gen were added to our analysis as previous studies
showed an effect of a high inflammatory response on
stroke outcome [31, 32].
Methods
The “Ludwigshafen Stroke Study” (LuSSt) is a pro-
spective population-based stroke register in Ludwigs-
hafen at Rhine in Germany, that started on January
1st, 2006 [33].
In order to achieve complete case ascertainment, mul-
tiple overlapping methods of patient identification were
used as described previously [33]. Case ascertainment of
hospitalized patients was ensured by collaboration with
all hospitals in the city of Ludwigshafen and hospitals in
the region. To identify all non-hospitalized stroke pa-
tients, general practitioners, specialists in internal medi-
cine, and neurologists practicing in Ludwigshafen were
informed about the register before study initiation and
were contacted together with nursing and residential
homes. All patients treated at “Klinikum Ludwigshafen”
were examined by a member of the study team, includ-
ing an interview based on a structured questionnaire as
described previously [34]. We intended to keep the
questions as simple as possible for interviews in acutely
ill patients. All patients who have been treated outside
“Klinikum Ludwigshafen” and gave informed consent,
were examined by a member of the study team. In the
other patients data were obtained by the attending phys-
ician and transmitted to the study center in pseudony-
mised form. In all patients with informed consent
follow-up investigations were performed by telephone 1,
3 and 12 months after stroke utilizing a standardized
questionnaire. If patients were unable to provide infor-
mations, a next-of-kin was interviewed. In patients
without informed consent, or without response to mul-
tiple telephone and letter contact attempts, survival and
death information was obtained by the population regis-
tration authority. LuSSt has been approved by the eth-
ics committee of the Landesärztekammer Rhineland-
Palatinate and by the data protection commissioner of
Rhineland-Palatinate.
Stroke was defined according to the definition of the
World Health Organization (WHO) [35]. Stroke subtype
classification was based on the results of brain imaging,
discriminating between IS, intracerebral hemorrhage
(ICH), and subarachnoid hemorrhage (SAH). In case
brain imaging was unavailable stroke type was defined as
undetermined. The present analysis comprises only pa-
tients with first-ever ischemic stroke up to December
31st, 2010. Patients with a first ischemic stroke and a
history of transient ischemic attack (TIA) were coded as
first-ever ischemic stroke according to comparable
population-based stroke registries [36]. Patients with re-
current stroke, TIA, SAH and ICH were excluded for
present analysis.
Outcome parameters and risk factors
Stroke severity was determined at hospital admission
using the National Institute of Health Stroke Scale
(NIHSS) [37]. In order to assess functional status prior
to stroke and functional outcome after first-ever ische-
mic stroke, modified Rankin Scale (mRS) was used [38,
39]. MRS is a 7-point scale ranging from 0 (no symp-
toms) to 6 (death). A score of 2 or less indicates func-
tional independence [40]. Loss of independence in daily
life was defined as a mRS > 2 summarizing patients that
had survived first 12 months after stroke with significant
disabilities, and deceased ones. Cardiovascular risk fac-
tors were defined according to current guidelines as de-
scribed previously [34, 41, 42]. Definitions have already
been described earlier [34, 43]. In brief, hypertension
was diagnosed if the patient was on antihypertensive
medication on admission, if hypertension had been diag-
nosed before by a physician or if blood pressure was >
140/90 mmHg in two or more measurements > 3 days
after stroke. Diabetes mellitus was defined in subjects
with fasting blood glucose level above 125 mg/dl in ven-
ous blood, present anti-diabetic medication at hospital
or known diagnosis of diabetes mellitus. Diagnosis of
atrial fibrillation (AF) has been made if permanent or par-
oxysmal AF was present on ECG or long-term monitoring
and additionally, in case of a history of this diagnosis. All
in-patients with cholesterol-lowering medication, fasting
cholesterol levels > 200 mg/dl or LDL-cholesterol >
140 mg/dl lead to diagnosis of Hypercholesterolemia. We
defined current smoking as present daily usage of any kind
of tobacco (at least one cigarette, cigar, cigarillo or pipe).
We classified history of smoking as smoking for any
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period of at least 6 months. Patients with previous angina
pectoris, myocardial infarction, coronary stenting or cor-
onary artery bypass were selected as subjects with coron-
ary artery disease (CAD) [34]. Patients with medical
history of peripheral artery disease (PAD), arterial bypass
surgery, stenting vessels of lower limbs and patients with
present intermittent claudication or history of intermittent
claudication of vascular origin were diagnosed PAD. Alco-
hol consumption as measured by self-report was coded if
> 1 drink per week was consumed on a regular base. An-
other selection criteria was consumption of alcohol in the
past.
We used definition of the German Olympic Sports As-
sociation for PA as formerly described: PA as any
leisure-time motor activity that had its aim in itself or
was performed for no other purpose than to improve or
maintain physical fitness [43]. Therefore, all activities
such as walking were defined as PA and had been in-
cluded. However, PA during work, PA on the way to or
from employment or activities like gardening were not
considered. All subjects were asked whether they had
regularly performed sports during the months before
stroke [30, 43]. Regular PA was acknowledged as such
activity at least once a week.
C-Reactive Protein (CRP) [particle-enhanced immuno-
turbidimetric assay CRPL3 (cobas®)], fibrinogen (Clauss
method on IL Coagulation Systems, Instrumentation La-
boratory) and leukocyte count (XE analyserXE-2100;
Sysmex) were determined < 48 h after admission.
Medical treatment
Thrombolysis was defined as intravenous application of
recombined tissue plasmin activator (rt-PA). During the
early years of LuSSt, mechanical recanalisation was not a
standard in acute stroke therapy, and therefore not cap-
tured in the database. Antiplatetlet treatment included
usage of one or more of these drugs: acetylsalicyl acid,
clopidogrel, dipyridamol with acetylsalicylic acid and in-
hibitors of glycopeptide IIb/IIIa.
Classification of stroke etiology
We used a modification of the TOAST (Trial of Org
10,172 in Acute Stroke Treatment) criteria to define etio-
logical subtypes of ischemic stroke [44]. Stroke due to
large-artery atherosclerosis, cardioembolism, small-artery
occlusion, stroke of other determined cause and stroke of
undetermined etiology (except such from two or more
competing etiologies) were diagnosed according to the
TOAST criteria. In addition, we diagnosed ‘probable
atherothrombotic stroke’ in such patients with stenosis <
50% diameter reduction on duplex sonography, CT-, MR-
or digital subtraction angiography and additional brain in-
farction(s) > 1.5 cm in the absence of any source of cardi-
oembolism. This category is comparable to “athero
thrombotic stroke” in the PERFORM study [45]. In pa-
tients with more than one potential cause for stroke, eti-
ology was assigned to the most likely causative me
chanism according to the SSS-TOAST classification [46].
Patients with stroke of unknown etiology were analyzed
retrospectively, specifically using embolic strokes of un-
determined source criteria (ESUS) and reclassified in
cryptogenic ESUS, cryptogenic NON-ESUS or stroke of
undetermined source (incomplete work-up or concurrent
stroke). Classification was performed by experienced neu-
rologists of the study team [47]. Controversial diagnoses
were discussed and agreed in study meetings.
Statistical methods
For univariate analyses χ2-test, t-test with and without
log-transformation and the Wilcoxon test were used as
appropriate. For multivariate analysis, logistic regression
was used. Variables being significant in univariate ana-
lyses were included in multivariable logistic regression
analysis using the backward elimination procedure. To
analyse the influence of early deaths after stroke, we
compared our full dataset (Model A) with results after
excluding patients who died early within the first 7 days
after stroke (Model B). In further analysis, patients with
“first ever ischemic stroke of unknown cause” were di-
vided into three groups: “cryptogenic ESUS”, “crypto-
genic NON-ESUS” and “stroke of undetermined source”
(stroke with incomplete work-up or concurrent stroke)
(Model C).
All data were analysed using SAS 9.4 software (SAS
Institute, North Carolina). All tests were performed for
two-sided testing. Level of significance was set to α =
0.05 for all tests.
Results
Between January 1st, 2006 and December 31st, 2010,
1547 cases of first-ever ischemic stroke were registered
in LuSSt. One-year follow-up information was available
for 1370 subjects (88.6%, 677 women and 693 men). In-
formation on mRS prior to stroke was available in 930
patients among whom 63 patients (4.6%) had a mRS > 2.
No significant differences between patients with and
without follow-up existed regarding age, sex and NIHSS
at admission (p > 0.1, respectively). Among the 1370 pa-
tients, 717 patients (52.3%) had poor outcome with loss
of functional independence including 251 (18.3%) pa-
tients who had died within the first year.
Clinical characteristics of all patients by one-year func-
tional outcome are shown in Table 1. In univariate ana-
lysis, female sex, higher age, higher NIHSS score at
admission, stroke etiology, higher leukocyte count,
higher fibrinogen level, antiplatelet drugs before stroke,
intravenous thrombolysis, arterial hypertension, AF,
CAD, hypercholesterolemia, diabetes mellitus, PAD,
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Table 1 Baseline characteristics, clinical characteristics and cerebrovascular risk factors by functional-outcome in 1370 patients with
first-ever ischemic stroke – univariate analysis
Predictor variable (number of
missing observations total)
One-year functional outcome
N (%) &Median (lower-upper quartile) p
valueTotal (n = 1370) mRS≤ 2 (n = 653) mRS > 2 (n = 717)
Sex (0) < 0.01
Men 693 (50.6) 385 (59) 308 (43)
Women 677 (49.4) 268 (41) 409 (57)
Age (mean ± SD;years) (0) 71.6; ±13 66.1; ±12.3 76.6; ±11.4 < 0.01
Vascular risk factors
Arterial hypertension (11) < 0.01
Yes 1195 (87.9) 549 (84.6) 646 (91)
No 164 (12.1) 100 (15.4) 64 (9)
Atrial fibrillation (36) < 0.01
Yes 391 (29.3) 112 (17.6) 279 (39.9)
No 943 (70.7) 523 (82.4) 420 (60.1)
Coronary heart disease (46) < 0.01
Yes 304 (23) 125 (19.7) 179 (25.9)
No 1020 (77) 509 (80.3) 511 (74.1)
Hypercholesterolemia (36) < 0.01
Yes 884 (66.3) 465 (72.5) 419 (60.5)
No 450 (33.7) 176 (27.5) 274 (39.5)
Diabetes (20) < 0.01
Yes 422 (31.3) 167 (25.9) 255 (36.1)
No 928 (68.7) 477 (74.1) 451 (63.9)
Peripheral arterial disease (51) < 0.01
Yes 132 (10) 46 (7.3) 86 (12.6)
No 1187 (90) 588 (92.7) 599 (87.4)
Smoking (0) < 0.01
Yes, actually 305 (22.3) 184 (28.2) 121 (16.9)
Yes, in the past 394 (28.8) 196 (30) 198 (27.6)
No 520 (38) 224 (34.3) 296 (41.3)
Unknown 151 (11) 49 (7.5) 102 (14.2)
Consumption of alcohola (80) < 0.01
Yes, actually 504 (39.1) 277 (44.3) 227 (34.1)
Yes, in the past 38 (2.9) 17 (2.7) 21 (3.2)
No 665 (51.6) 302 (48.3) 363 (54.6)
Unknown 83 (6.4) 29 (4.7) 54 (8.1)
Regular physical activity (0) < 0.01
Yes 266 (19.4) 187 (28.6) 79 (11)
No 1104 (80.6) 466 (71.4) 638 (89)
Clinical characteristics on admission
NIHSS (33)b 3 (2–6) 2 (1–4) 5 (3–11) < 0.01
TOAST (0) < 0.01
Probable atherothrombotic 208 (15.2) 98 (15) 110 (15.3)
Cardioembolic 422 (30.8) 143 (21.9) 279 (39)
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smoking status, alcohol consumption, regular PA prior
to stroke and mRS > 2 at discharge were associated with
one-year poor functional outcome or loss of independ-
ence. Among 117 patients with ischemic stroke of un-
known etiology, stroke workup was incomplete in 39
(33.3%) patients, cryptogenic stroke was diagnosed in 60
(51.3%) patients and more than one possible etiology for
ischemic stroke was evident in 18 patients (15.4%).
Among patients with cryptogenic stroke, ESUS was diag-
nosed in 40 (66.7%) patients.
In multivariate analysis, lack of regular PA prior to
stroke (OR 1.7; CI 1.1–2.5) independently predicted
poor outcome together with female sex (OR 1.5; CI 1.1–
2.1), higher age (65–74: OR 1.7; CI 1.1–2.8, 75–84 years:
OR 3.3; CI 2.1–5.3; ≥85 years OR 14.5; CI 7.4–28.5),
higher NIHSS on admission (OR 1.2; CI 1.1–1.2), dia-
betes mellitus (OR 1.8; CI 1.3–2.5), probable athero-
thrombotic stroke (OR 1.8; CI 1.1–2.8) mRS > 2 at
hospital discharge (OR 8.9; CI 6.0–13.0) and leukocyte
count of > 9.000/mm3 (OR 1.4; CI 1.0–1.9);(Table 2,
Model A). Threshold that was reported in previous stud-
ies [48]. Exclusion of patients who died < 7 days after
stroke (Model B) resulted in comparable results.
Subclassifying patients with unknown stroke etiology
the diagnosis of cryptogenic ESUS showed a trend
towards loss of functional outcome or death (OR 2.2; CI
0.9–5.5) whereas cryptogenic Non-ESUS stroke did not
(OR 1.3; CI 0.5–3.7) (Table 2, Model C).
Discussion
In addition to well known predictors of stroke outcome
we identified lack of regular PA prior to stroke, high
leukocyte count, probable atherothrombotic stroke eti-
ology as independent predictors of poor functional out-
come. Stroke severity (measured by NIHSS or mRS),
diabetes mellitus and higher age are well established in-
dependent predictors for poor stroke outcome [7, 49–
53]. Recently published scoring systems also used pa-
rameters like arterial hypertension, AF, higher age, sex,
blood glucose, level of consciousness, stroke type or se-
verity to predict stroke outcome [3, 7, 54, 55]. Factors
like arterial hypertension, AF, CAD, hypercholesterol-
emia, PAD, smoking status and alcohol consumption
were not independent predictors for loss of functional
independence in our population. This may partly be ex-
plained by too low numbers of subjects in our study,
resulting in insufficient statistical power to detect pre-
dictors with moderate impact. Moreover, differences be-
tween study populations in risk factor control and
compliance to medication intake (e.g. oral anticoagulants
Table 1 Baseline characteristics, clinical characteristics and cerebrovascular risk factors by functional-outcome in 1370 patients with
first-ever ischemic stroke – univariate analysis (Continued)
Predictor variable (number of
missing observations total)
One-year functional outcome
N (%) &Median (lower-upper quartile) p
valueTotal (n = 1370) mRS≤ 2 (n = 653) mRS > 2 (n = 717)
Large-artery atherosclerosis 192 (14) 85 (13) 107 (14.9)
Small-artery occlusion 369 (27) 237 (36.3) 132 (18.4)
Other determined 62 (4.5) 28 (4.3) 34 (4.7)
Unknown 117 (8.5) 62 (9.5) 55 (7.7)
Leukocytes (47)b 8.3 (6.8–10.2) 7.9 (6.6–9.7) 8.6 (7.0–10.7) < 0.01
Fibrinogen (86)b 370 (318–434) 356 (309–412) 386 (329–455) < 0.01
Antiplatlet drugs (0) < 0.01
Yes 480 (35) 197 (30.2) 283 (39.5)
No 890 (65) 456 (69.8) 434 (60.5)
Lysis therapy (0) < 0.01
Yes 124 (9.1) 37 (5.7) 87 (12.1)
No 1246 (90.9) 616 (94.3) 630 (87.9)
Clinical characteristics at discharge
NIHSS (109)b 2 (1–4) 1 (0–2) 3 (1–7) < 0.01
mRS (94)
≤ 2 (0–2) 838 (65.7) 573 (92) 265 (40.6) < 0.01
> 2 (3–6) 438 (34.3) 50 (8) 388 (59.4)
Comparisons by X2-test, Student’s t-test with and without log-transformation and Wilcoxon test as appropriate
mRS modified Rankin Scale, N number, NIHSS National Institutes of Health Stroke Scale, SD standard deviation, TOAST Trial of ORG 10172 in Acute Stroke
Treatment; a > 1 drink per week; b Quartiles
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in AF) may be accountable for variations between
studies.
Lack of regular physical activity is a modifiable risk
factor for both, ischemic and hemorrhage stroke [56–
58]. PA reduces stroke risk by lowering blood pressure,
improving lipid and glucose metabolism and endothelial
function. Further benefits are reduction of thrombocyte
aggregation and blood viscosity [58]. Recently published
studies showed endothelial function and atherogenesis
to be influenced by PA [59, 60]. Improved physical fit-
ness results in better control of risk factors like
hypertension and diabetes mellitus and this could have
contributed to the beneficial effect of PA on stroke out-
come in our study. Patients who had engaged in regular
PA may be in better physical and mental conditions and
have more capacity to cope with the sequelae of stroke.
An association between prognosis after stroke and previ-
ous PA had been reported in few studies so far [56–58].
In the Framingham study there was no reduction for
stroke risk beyond a moderate level of physical activity
[26]. We therefore used comparable low threshold (≥1
per week) to define regular PA in our study. Physical
Table 2 Results of multivariate logistic regression analysis on 1-year functional outcome after first-ever ischemic stroke. Model A (all
observations), Model B (excluding patients that had died early within 0–7 days after hospital admission) and Model C (all
observations with subanalysis of the first-ever ischemic stroke “Unknown cause”). Observations with one or more missing variables
have been dropped from multivariate analysis. Bold values indicate significance at p < 0.05. Adjusted for age, diabetes mellitus and
stroke severity
Predictor variable Model A n = 1234 Model B n = 1230 Model C n = 1234
OR (95% CI) p value OR (95% CI) p value OR (95% CI) p value
Sex
(W vs M) 1.5 (1.1–2.1) 0.01 1.5 (1.1–2.1) 0.01 1.5 (1.1–2.1) 0.01
Age, years (vs 55–64)
< 55 0.4 (0.2–0.8) 0.01 0.3 (0.2–0.8) 0.01 0.4 (0.2–0.8) 0.01
65–74 1.7 (1.1–2.8) 0.03 1.7 (1.1–2.8) 0.03 1.7 (1.0–2.8) 0.03
75–84 3.3 (2.1–5.3) < 0.01 3.3 (2.1–5.3) < 0.01 3.3 (2.0–5.3) < 0.01
≥ 85 14.5 (7.4–28.5) < 0.01 14.5 (7.4–28.5) < 0.01 14.4 (7.4–28.3) < 0.01
Regular Physical Activity
(No vs Yes) 1.7 (1.1–2.5) < 0.01 1.7 (1.1–2.5) < 0.01 1.7 (1.1–2.5) < 0.01
Diabetes
(Yes vs No) 1.8 (1.3–2.5) < 0.01 1.9 (1.3–2.95 < 0.01 1.8 (1.3–2.5) < 0.01
Leukocyte count
(≥ 9 vs < 9 × 1000/mm3) 1.4 (1.0–1.9) 0.04 1.4 (1.0–1.9) 0.05 1.4 (1.0–1.9) 0.04
TOAST
(vs Small-artery occlusion)
Probable atherothrombotic 1.8 (1.1–2.8) 0.02 1.8 (1.0–2.8) 0.02 1.8 (1.1–2.8) 0.02
Cardioembolic 1.4 (0.9–2.1) 0.12 1.4 (0.9–2.1) 0.13 1.4 (0.9–2.1) 0.12
Large-arthery
Atherosclerosis
1.4 (0.9–2.3) 0.17 1.4 (0.9–2.3) 0.17 1.4 (0.9–2.3) 0.17
Other determined 2.0 (0.9–4.4) 0.09 2.0 (0.9–4.4) 0.09 2.0 (0.9–4.4) 0.09
Unkown 1.5 (0.8–3.0) 0.21 1.5 (0.8–3.0) 0.21
Cryptogenic ESUS 2.2 (0.9–5.5) 0.10
Cryptogenic NON-ESUS 1.3 (0.5–3.7) 0.62
Undetermined source 0.9 (0.2–3.8) 0.94
mRS at hospital discharge
(≥ 3 vs < 3) 8.9 (6.0–13.3) < 0.01 8.9 (6.0–13.3) < 0.01 8.9 (6.0–13.4) < 0.01
NIHSS on admission
(per point) 1.2 (1.1–1.2) < 0.01 1.2 (1.1–1.2) < 0.01 1.2 (1.1–1.2) < 0.01
ESUS embolic stroke of unknown source, mRS modified Rankin Scale, NON-ESUS no embolic stroke of unknown source, N number, NIHSS National Institutes of
Health Stroke Scale, SD standard deviation, TOAST Trial of ORG 10172 in Acute Stroke Treatment;
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handicap before stroke was seldom observed (mRS > 2
in only 4.9% of patients) in our patients and did thus,
not explain the association between lack of PA and out-
come. A strength of our study is higher number of cases
and prospective study design compared to other studies.
However, our findings should be ascertained by further
prospective studies. PA is a modifiable lifestyle risk fac-
tor with a major importance in preemptive strategies to
prevent strokes and improve mid-term stroke outcome.
For future stroke care, PA as a modifiable risk factor
should get more focus in stroke research as well as in
primary and secondary stroke care. Documenting and
focusing on regular PA might have great impact in pri-
mary stroke care leading to better stroke outcomes and
more functional independence. Being physically active in
mid-life increases the odds of being active in old age
[61]. However, more research is necessary, e.g. to find
out how much PA preceeding first-ever ischemic stroke
reduces stroke severity. Visual representation of the
overall distribution of mRS 12 months post stroke draws
a clear picture of difference by PA activity pre stroke.
Even if a part of the difference is attributable to other
confounding factors, like NIHSS on admission and mRS
at hospital discharge, the cumulative barchart visualizes
striking difference of outcomes in favour of PA. In con-
trast to other studies, we used definition of the German
Olympic Sports Association. Registration of leisure-time
motor activity only might result in underestimation of
physical activity.
Higher leukocyte count was associated with lack of
functional independence in our population indicating
that the strength of the early inflammatory response her-
alds poor prognosis independent of clinical stroke sever-
ity and factors that are known to contribute to leukocyte
counts such as smoking and diabetes mellitus. Infection
before ischemia is an established stroke trigger factor
which may partly explain the association between
leukocyte count and poor prognosis, as well as larger in-
farct volume which was not investigated in our study
[31, 32]. Blood samples were taken within 24 h in the
majority of patients; therefore it is unlikely that
leukocytosis was due to stroke related infections such as
post-stroke pneumonia.
In line with other studies, female sex proved to be an
independent predictor for lack of functional independ-
ence [7, 62]. Gall et al. hypothesized that females are
more vulnerable than men because of differences in
chronic diseases, socioeconomic status and medical his-
tories [63]. Females are more likely to suffer from severe
strokes [62, 64]. A further reason might be the
sex-related differences in muscular strength, or different
approaches to handle their disabilities. This difference
between sexes may increase in the elderly, because the
observed decline in muscle strength with aging is also
related to a reduction in PA, normally different between
sexes. In people older than 65 years, less than one third
of all women performed some PA - compared to men
with 47.9%. Elderly women with a higher body mass
index have a lower status of PA [65]. Moreover, female
patients have a higher risk of walking with a cane [66].
More focus on PA in middle-life could improve level of
PA in elderly people [61]. Additionally, more frequent
occurrence of depression and lack of social support may
increase probability for loss of functional independence
in females [7, 55, 67]. However, most authors used uni-
variate analyses and did not adjust for confounders.
Regarding stroke etiology, probable atherothrombotic
stroke was an independent predictor for loss of func-
tional independence in our population. The category of
stroke of probable atherothrombotic etiology includes
patients with distinct signs of non-stenosing arterioscler-
osis as a marker of probable atherosclerotic plaques
mostly at the orifices of small penetrating arteries, such
as lenticulostriate arteries. CAD and PAD, that were as-
sociated with loss of functional independence in univari-
ate but not in multivariate analysis are other common
atherosclerotic diseases and may have contributed to
some degree to the effect of this etiologic subgroup. This
group may also include some patients with cardioem-
bolic strokes due to non-detected AF. In contrast to
other studies, cardioembolism was not independently as-
sociated with poor functional outcome in multivariate
analysis. Cardioembolic stroke results in higher stroke
severity. Adjustment for NIHSS and mRS at discharge
presumeably prompted lack of significance of cardioem-
bolism in our study.
In 117 patients stroke etiology was classified as stroke
of unknown origin. Further analysis identified crypto-
genic strokes and ESUS as main contributors to this
group. Two thirds of patients with cryptogenic strokes
were diagnosed as cryptogenic ESUS and tended to be
associated with loss of functional independence, a find-
ing that did not reach statistical significance due to small
numbers. These cases may partly represent patients with
non-detected AF and without any kind of anticoagula-
tion. More effort in detecting AF in patients with ESUS
may reduce recurrence of IS and improve functional
outcome.
There are strengths and limitations to this study. The
data were derived from a population–based stroke regis-
ter, including both hospitalized and non-hospitalized pa-
tients without age-restrictions. Data have been collected
prospectively by applying standardized protocols using
multiple notification sources widely ensuring complete
case ascertainment. Robust quality of case ascertainment
is indicated by stable incidence rates over time. A high
rate of neuroimaging (98.2%) assures high reliability of
first-ever ischemic stroke diagnosis. An intense clinical
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work-up together with the application of modified
TOAST criteria resulted in a low number of patients
with undefined stroke causes [48]. This enabled us to
study a relatively large cohort of unselected patients,
resulting in sufficient statistical power to determine dif-
ferences in stroke outcome. Our study is characterized
by a high rate of follow-up and low rates of missing
values (< 5%). Observed early death rates in our study
were similar to findings in other population-based stroke
registers [36, 68].
Limitations of our current work include the lack of
data on the quality of risk factor control and the ex-
ploratory character of our results on factors like previous
PA without possibility to reanalyze the detected results
in a derivation sample. Further statistical limitation is
lack of a power as LuSSt is primarily descriptive. Add-
itionally, PA after stroke has not been assessed and an
overestimation in amount of sports activity might result
in another bias: acquisition of self-reported patients data
increase the possibility of a misclassification bias. Distant
events are often not precisely recalled, also raising the
possibility of recall bias, particularly for sports in early
adulthood. In contrast to other studies on physical activ-
ity using WHO definition, we used definition of the Ger-
man Olympic Sports Association. Furthermore, poor
outcome had not included standardized patient reported
outcome measures like Euro-QOL-5, Frenchay Activities
Index, HAD’s depression or PROMIS-10 [55, 69–71].
Conclusion
In addition to broadly accepted risk factors for poor
functional outcome we found that lack of PA prior to
stroke, high leukocyte count at admission and probable
atherothrombotic stroke etiology may constitute import-
ant independent predictors of loss of functional inde-
pendence after first-ever ischemic stroke.
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